19 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Iagaru, Nuclear Radiologist in Pleasanton, CA?
Dr. Andrei Iagaru, MD is a Nuclear Radiologist, who primarily practices in Pleasanton, CA with 2 additional practice locations. He has been practicing for over 19 years and is board certified. Dr. Iagaru graduated from Universitatea de Medicina si Farmacie Carol Davila and completed his residency at Stanford University Program. Dr. Iagaru is fluent in English and Romanian; Moldavian; Moldovan, and is currently seeing new patients. Dr. Iagaru’s practice accepts Kaiser Permanente, Medicaid, Medicare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Iagaru’s office at (650) 723-4000.
Where did Dr. Iagaru go to medical school and complete their residency?
Residency: Stanford University Program
Medical School: Carol Davila University of Medicine & Pharmacy | Universitatea de Medicina si Farmacie Carol Davila
Is Dr. Iagaru board certified as a Nuclear Radiologist?
Yes, Dr. Andrei Iagaru, MD is board certified by the American Board of Nuclear Medicine
What languages does Dr. Iagaru speak?
Dr. Iagaru and their clinical team can communicate with patients in the following languages:
English
Romanian; Moldavian; Moldovan
What conditions does a Nuclear Radiologist like Dr. Iagaru typically treat?
As a Nuclear Radiologist, Dr. Iagaru diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. Iagaru. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly. Learn more about our claims-based healthcare methodology.
Also known as:
- Age-Related Osteoporosis
- Fractures
- Osteoporosis
- Senile Osteoporosis
- Primary Osteoporosis
- Bone Thinning from Aging
ICD-10 Codes:
- M810: Age-related osteoporosis without current pathological fracture
Also known as:
- Multiple Site Bone Density and Structure Disorder
- Bone Density
- Bone Disease
- Widespread Bone Density Disorder
- Generalized Bone Structure Problem
- Multi-site Bone Disorder
ICD-10 Codes:
- M8589: Other specified disorders of bone density and structure, multiple sites
Also known as:
- Prostate Cancer
- Prostate Cancer Treatment (PDQ®)
- Prostatic Carcinoma
- Prostate Gland Cancer
- Malignant Prostate Tumor
ICD-10 Codes:
- C61: Malignant neoplasm of prostate
Also known as:
- Chest Pain
- Chest discomfort
- Thoracic pain
- Upper body pain
ICD-10 Codes:
- R079: Chest pain, unspecified
Also known as:
- Multiple Myeloma
- Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
- Active multiple myeloma
- Untreated multiple myeloma
- Plasma cell myeloma
ICD-10 Codes:
- C9000: Multiple myeloma not having achieved remission
Also known as:
- Asymptomatic Menopause
- Menopause
- Menopausal Transition
- Postmenopause
- Change of Life
ICD-10 Codes:
- Z780: Asymptomatic menopausal state
What procedures does a Nuclear Radiologist like Dr. Iagaru typically perform?
As a Nuclear Radiologist, procedures performed by Dr. Andrei Iagaru may include:
- Abdominal Aortic Aneurysm (AAA) Screening
- Abdominal Imaging
- Abdominal Radiology Consultation
- Angiography
- Arthrography
- Barium Swallow
- Bone Biopsy
- Bone Density Measurement / DXA Scan
Please contact Dr. Iagaru's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Iagaru accept my insurance?
Dr. Iagaru accepts most major insurance plans. Important: Please call our office at (650) 723-4000 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Iagaru accept in Pleasanton, CA?
Dr. Iagaru in Pleasanton, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
Advantage
Blue Shield of California
Cigna Group
CVS Health (formerly Aetna)
Medicaid
Medicare
Other Provider Networks
Santa Cruz County
State of California
UnitedHealth Group
View All Insurances
Where is Dr. Iagaru's office located?
Dr. Andrei Iagaru's Primary Practice
5555 W Las Positas Blvd
Pleasanton, CA 94588
(650) 723-4000
What hospitals are Dr. Iagaru affiliated with?
Castle Connolly Top Hospital
This doctor is affiliated with a Castle Connolly Top Hospital.
Dr. Iagaru has admitting privileges at the following hospitals:
Stanford Health Care - Stanford Hospital,Stanford, CA
Ranked in 6 Procedures
Ranked in 6 Procedures
Stanford Health Care - Valleycare,Pleasanton, CARanked in 2 Procedures
Ranked in 2 Procedures
Clovis Community Medical Center,Clovis, CA
Gold Standard Top Hospital
Ranked Heart & Vascular Surgery
Ranked in 2 Procedures
Gold Standard Top Hospital
Ranked Heart & Vascular Surgery
Ranked in 2 Procedures
Stanford Health Care Emeryville 5800,Emeryville, CA
Stanford Health Care - Emeryville,Emeryville, CA
Lucile Packard Childrens Hospital Stanford,Palo Alto, CA
Recognitions
Publications
18F-FDG PET/CT in the magement of patients with post-transplant lymphoproliferative disorder.
, 2014
The Clinical Use of PET/CT in the Evaluation of Melanoma.
, 2014
Prognostic utility of 90Y radioembolization dosimetry based on fusion 99mTc-macroaggregated albumin
, 2013
Root cause alysis of gastroduodel ulceration after yttrium-90 radioembolization.
, 2013
Prognostic Utility of Y-90 Radioembolization Dosimetry Based on Fusion Tc
, 2013
Combined F-18-fluoride and F-18-FDG PET
, 2013
Safety of repeated yttrium-90 radioembolization.
, 2013
Imaging Tumor Angiogenesis: The Road to Clinical Utility
, 2013
An Observatiol Study of Circulating Tumor Cells
, 2013
Pilot prospective evaluation of 99mTc-MDP scintigraphy, 18F F PET/CT
, 2013
Second Sino-American Conference on Nuclear Medicine
, 2013
Combined F-18-Fluoride and F-18-FDG PET
, 2013
18F-FDG PET/CT Demonstration of Diffuse Lymphohistiocytic Granulomatous Vasculitis.
Initial investigation of F-18-F PET
, 2012
The Impact of Partial Volume Correction in the Evaluation of Solitary Pulmory Nodules by FDG PET
, 2012
Positron Emission Tomography of Cu-64
, 2012
F-18-FDG PET/CT Demonstration of a Liver Metastasis in a Patient With Papillary Thyroid Cancer
, 2012
Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer
, 2012
Prognostic Value of Metabolic Tumor Volume and Velocity in Predicting Head-and-Neck Cancer Outcomes
, 2012
Prospective Evaluation of Tc-99m MDP Scintigraphy, F-18 F PET/CT
, 2012
Demonstration of peripheral nerve root involvement by non-Hodgkin's lymphoma on F-18-FDG PET/CT
, 2012
Prospective comparison of combined F-18-FDG
, 2012
Response to Intra-Arterial Oncolytic Virotherapy with the Herpes Virus NV1020 Evaluated by [F
, 2012
Correlation between metabolic tumor volume
, 2011
PET/CT Imaging of Thyroid Cancer
, 2011
Pilot Pharmacokinetic and Dosimetric Studies of F-18-FPPRGD2
, 2011
FDG-PET/CT in Cancers of the Head and Neck: What is the Definition of Whole Body Scanning?
, 2011
Thyroid Stunning: Fact or Fiction?
, 2011
Case 166: Metastatic Left Pulmory Artery Sarcoma
, 2011
(18)F-FDG PET/CT: timing for evaluation of response to therapy remains a clinical challenge.
, 2011
Current concepts and future directions in radioimmunotherapy.
, 2010
F-18 FDG PET/CT Demonstration of Lymphohistiocytic Meningitis
, 2010
I-131-Tositumomab (BexxarA (R)) vs. Y-90-Ibritumomab (Zevali (R)) Therapy of Low-Grade Refractory
, 2010
Combined F-18-FDG and Fluoride Approach in PET/CT Imaging: Is There a Clinical Future? REPLY
, 2010
Efficacy of F-18-FDG PET/CT in the evaluation of patients with recurrent cervical carcinoma
, 2009
Efficacy of F-18-FDG PET/CT for Breast Cancer
, 2009
Evaluation by F-18-FDG-PET of patients with al squamous cell carcinoma
, 2009
Tumor Metabolic Phenotypes on F-18 FDG PET REPLY
, 2009
Incorporating Cone-beam CT into the Treatment Planning for Yttrium-90 Radioembolization
, 2009
Novel Strategy for a Cocktail F-18-Fluoride and F-18-FDG PET
, 2009
F-18-FDG PET/CT evaluation of patients with ovarian carcinoma
, 2008
Y-90-Ibritumomab Therapy in Refractory Non-Hodgkin's Lymphoma
, 2008
Rhabdomyosarcoma diffusely metastatic to the bone marrow
, 2008
F-18-FDG-PET/CT evaluation of response to treatment in lymphoma
, 2008
Perspectives of molecular imaging and radioimmunotherapy in lymphoma
, 2008
I-123 MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
, 2008
F-18FDG PET and PET/CT evaluation of response to chemotherapy in bone and soft tissue sarcomas
, 2008
Molecular imaging can accelerate anti-angiogenic drug development and testing
, 2007
F-18 FDG PET/CT in the magement of thyroid cancer
, 2007
Advances in metabolic imaging for surgical oncology
, 2007
Detection of occult medullary thyroid cancer recurrence with 2-deoxy-2-[F-18]fluoro-D-glucose-PET
, 2007
Treatment of thyrotoxicosis
, 2007
F-18 FDG PET visualization of uriry leak after nephrostomy tube removal
, 2007
Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET
, 2007
2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography
, 2007
F-18FDG PET/CT demonstration of an adrel metastasis in a patient with aplastic thyroid cancer
, 2007
Breast MRI and F-18 FDG PET/CT in the magement of breast cancer
, 2007
F-18FDG PET/CT evaluation of osseous and soft tissue sarcomas
, 2006
F-18-FDG PET and PET/CT for detection of pulmory metastases from musculoskeletal sarcomas
, 2006
2-Deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography and positron emission tomography
, 2006
Demonstration of an ectopic mediastil parathyroid adenoma on Tc
, 2006
PET/CT follow-up in nonossifying fibroma
, 2006
F-18FDG PET imaging of uriry bladder oat cell carcinoma with widespread osseous metastases
, 2006
Merkel cell carcinoma
, 2006
F-18FDG PET evaluation of bronchial plasmacytoma with CT and MRI correlation
, 2006
Demonstration of a right inguil hernia containing uriry bladder diverticulum on whole
, 2006
Failed atrial septal defect repair versus pulmory hypertension with right ventricular failure
, 2005
FDG PET-CT demonstration of Sjogren's sialoadenitis
, 2005
What is Dr. Iagaru's NPI number?A National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Iagaru's National Provider Identifier (NPI) number is 1750404752.
What common questions do patients ask about Dr. Iagaru?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Iagaru
What is Dr. Andrei Iagaru's specialty?
Dr. Iagaru is a Nuclear Radiologist near Pleasanton, CA.
What does a Nuclear Radiologist do?
A nuclear radiologist has expertise in the analysis of nuclear medicine and utilizes radionuclides and radiolabeled substances for both in vitro and in vivo diagnostics. Additionally, they administer these substances for the treatment of various diseases.
Is Dr. Andrei Iagaru affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. Iagaru is affiliated with Stanford Health Care - Stanford Hospital, Stanford Health Care - Valleycare, Clovis Community Medical Center which are a Castle Connolly Top Hospitals. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
When to see a Nuclear Radiologist?: Guides for symptoms, conditions, and treatments
Understand your symptoms and know when it’s time to see a Nuclear Radiologist. Explore insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Dr. Andrei Iagaru accepting new patients in Pleasanton, CA?
Yes, Dr. Andrei Iagaru is accepting new patients at this time.
Does Dr. Andrei Iagaru offer online booking?
Please contact Dr. Iagaru's office at (650) 723-4000 for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Dr. Andrei Iagaru?
Please contact Dr. Iagaru's office at (650) 723-4000 to schedule an appointment.
Where is Dr. Iagaru's office located?
Dr. Iagaru's offices are located in Pleasanton, CA, Stanford, CA, and Emeryville, CA.
Which board certifications does Dr. Andrei Iagaru have?
Dr. Andrei Iagaru is certified by the American Board of Nuclear Medicine.
Other Nuclear Radiologist Near Pleasanton, CA
Nuclear Radiologist
Accepting patients
Nuclear Radiologist
Accepting patients
Diagnostic Radiologist
Accepting patients